University of North Carolina at Chapel Hill researchers have developed a new drug delivery platform that harnesses helical amyloid fibers designed to untwist and release drugs in response to body temperatures.
Feb 21, 2024
0
26
A UCF cancer researcher is discovering ways that the body's own natural killer (NK) cells can be energized to fight deadly pediatric cancers and improve immunotherapy by unleashing the power of our immune system.
Jan 30, 2024
0
0
Researchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI). This is the first peer-reviewed publication from the two organizations' ...
Jan 23, 2024
0
0
In a rapid communication published in the journal Genes & Diseases, researchers from Chongqing Medical University and Yongchuan Traditional Chinese Medicine Hospital of Chongqing have unveiled crucial insights into the factors ...
Dec 15, 2023
0
0
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia ...
Nov 30, 2023
0
58
In an ever-evolving world of big data, more powerful analytics, and the application of artificial intelligence fueled in part by consumer, research and patient data, the American Heart Association has released new policy ...
Aug 30, 2023
0
1
A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation ...
Aug 18, 2023
0
114
The National Institutes of Health is releasing a comprehensive dataset that standardizes genomic, proteomic, imaging, and clinical data from individual studies of more than 1,000 tumors across 10 cancer types. Researchers ...
Aug 14, 2023
0
5
Research led by Peking University, China, has looked into gut microbiota production of isozymes, which do similar work to human enzymes but have different structures.
In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body's initial ...
Aug 8, 2023
0
28
